Zealand Pharma announces FDA acceptance of New Drug Application for the dasiglucagon HypoPal® rescue pen for treatment of severe hypoglycemia
Company Announcement – No. 28 / 2020Zealand Pharma announces FDA acceptance of New Drug Application for the dasiglucagon HypoPal® rescue […]